Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis

Arthritis and Rheumatism

Volumn 42, Issue 3, 1999, Pages 545-554

  Smith Jr , Gerald N ^a   Myers, Stephen L ^a   Brandt, Kenneth D ^a   Mickler, Elizabeth A ^a   Albrecht, Marjorie E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIACETYLRHEIN;

ANIMAL EXPERIMENT; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; DISEASE SEVERITY; DOG; DOSE RESPONSE; DRUG EFFECT; KNEE ARTHROSCOPY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROSCOPY; CARTILAGE, ARTICULAR; COLLAGENASES; DISEASE MODELS, ANIMAL; DOGS; FEMUR; JOINT INSTABILITY; KNEE JOINT; ORGAN CULTURE TECHNIQUES; OSTEOARTHRITIS; PROTEOGLYCANS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0345196596     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:3<545::AID-ANR20>3.0.CO;2-4     Document Type: Article

References (34)

1. DiPasquale G. Pharmacological control of cartilage degradation in osteoarthritis. In: Woessner JF, Howell DS, editors. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker; 1993. p. 475-501.
2. Altman RD, Howell DS. Disease-modifying osteoarthritis drugs. In: Brandt KD, Doherty M, Lohmander LS, editors. Osteoarthritis. New York: Oxford University Press; 1998. p. 417-28.
3. Lesquesne M, Brandt K, Bellamy N, Moskowitz R, Menkes CJ, Pelletier J-P, et al. Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol 1994;21 Suppl 41:65-73.
4. Pomarelli P, Berti M, Gatti MT, Mosconi P. A non-steroidal anti-inflammatory drug that stimulates prostaglandin release. Farmaco 1980;35:836-42.
5. Franchi-Micheli S, Lavacchi L, Friedmann CA, Zilletti L. The influence of diacerhein on the biosynthesis of prostaglandin-like substances in vitro. J Pharm Pharmacol 1983;35:262-4.
6. La Villa G, Marra F, Laffi G, Belli B, Meacci E, Fascetti P, et al. Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. Eur J Clin Pharmacol 1989;37:1-5.
7. Petrillo M, Montrone F, Ardizzone S, Caruso I, Blanchi Porro G. Endoscopic evaluation of diacerhein-induced gastric mucosal lesions. Curr Ther Res 1991;49:10-5.
8. Pujol JP. Collagenolytic enzymes and interleukin 1: their role in inflammation and cartilage degradation; the antagonistic effects of diacerhein on IL-1 action on cartilage matrix components [abstract]. Osteoarthritis Cartilage 1993;1:82.
9. Cruz T, Tang J, Pronost S, Pujol J-P. Mécanismes moléculaires impliqués dans l'inhibition de l'espression de la collagénase par la diacerhéine. Rev Praticien 1996;S6:15-9.
10. Lingetti M, D'Ambrosio PL, Di Grezia F, Sorrentino P, Lingetti E. A controlled study in the treatment of osteoarthritis with diacerhein (Artrodar). Curr Ther Res 1982;31:408-12.
11. Marcolongo R, Fioravanti A, Adami S, Tozzi E, Mian M, Zampieri A. Efficacy and tolerability of diacerhein in the treatment of osteoarthrosis. Curr Ther Res 1988;43:878-87.
12. Nguyen M, Dougados M, Berdah L, Amor B. Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994;37: 529-36.
13. Maziéres B, Berdah L, Thiechart G, Viguier G. étude de la diacerhéine sur un modéle postcontusif d'arthrose expérimentale chez le lapin. Rev Rheum 1993;60:S77-81.
14. O'Connor B, Palmoski M, Brandt K. Neurogenic acceleration of degenerative joint lesions. J Bone Joint Surg Am 1985;67-A:562-72.
15. Brandt KD, Smith G, Kang SY, Myers S, O'Connor B, Albrecht M. Effects of diacerhein in an accelerated canine model of osteoarthritis. Osteoarthritis Cartilage 1997;5:438-49.
16. Myers SL, Brandt KD, O'Connor BL, Visco DM, Albrecht ME. Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection: effect of surgical hemostasis. Arthritis Rheum 1990;33:1406-15.
17. Ayral X, Dougados M, Listrat V, Bonvarlet J-P, Simonnet J, Amor B. Arthroscopic evaluation of chondropathy in osteoarthritis of the knee. J Rheumatol 1996;23:698-706.
18. Smith GN Jr, Myers SL, Brandt KD, Mickler EA. Effect of intraarticular hyaluronan injection in experimental canine osteo-arthritis. Arthritis Rheum 1998;41:976-85.
19. Mankin HJ, Dorfman H, Lippiello Z, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1997;53A:523-37.
20. Brandt K, Muir H. Characterization of protein-polysaccharides of articular cartilage from mature and immature pigs. Biochem J 1966;114:871-6.
21. Brandt K, Albrecht M. Effect of naproxen sodium on the net synthesis of glycosaminoglycans and protein by normal canine articular cartilage in vitro. J Pharm Pharmacol 1990;42:738-40.
22. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 1962;4:330-4.
23. Dean DD, Martel-Pelletier J-P, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84: 678-85.
24. Dean DD, Martel-Pelletier J-P, Howell, DS, Woessner JF Jr. Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases. Biochem J 1984;218:277-80.
25. Dean DD, Curry TE, LeMaire WJ, Woessner JF Jr. Determination of metalloproteinase activity after selective destruction of tissue inhibitor of metalloproteinases [abstract]. Trans Orthop Res Soc 1987;12:248.
26. 14C) acetylated collagen. Anal Biochem 1979; 99:340-5.
27. McDevitt CA, Gilbertson E, Muir H. An experimental model of osteoarthritis; early morphological and biochemical changes. Ann Rheum Dis 1977;34:15-25.
28. Vignon EM, Arlot D, Hartman D, Moyer B, Wille G. Hypertrophic repair of articular cartilage in experimental osteoarthrosis. J Rheumatol 1983;142:82-8.
29. Adams ME, Brandt KD. Hypertrophic repair of canine articular cartilage in osteoarthritis after anterior cruciate ligament transection. J Rheumatol 1991;18;428-35.
30. Brandt KD, Myers SL, Burr D, Albrecht M. Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum 1991;34:1560-70.
31. Yu LP, Smith GN, Brandt KD, Myers SL, O'Connor BL, Brandt DA. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35: 1150-9.
32. Ghosh P. Evaluation of the effects of diacerhein on cartilage and subchondral bone in an ovine model of osteoarthritis [abstract]. 5th International Congress: Research and Therapeutics in Osteoarthritis, Interleukin-1 Inhibitors; 1998 Jan 31-Feb 1; Mandelieula-Napoule, France. p.10.
33. Martel-Pelletier J, Mineau F, Jolicoeur F-C, Cloutier J-M, Pelletier J-P. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-α systems in human osteoarthritic synovium and chondrocytes. J Rheumatol 1998;25:753-62.
34. Cruz T. Effect of diacerhein on matrix metalloproteinases [abstract]. 3rd International Congress: Research and Therapeutics in Osteoarthritis, Interleukin-1 Inhibitors; 1996 Feb 3-4; Cannes, France. p. 8.